There are 3 papers on REV1 in aging research: 1 observational study in people, 2 in animals.
At a glance
The findings reach mice, none yet in people. 1 lab in 1 country.
None of its findings points the other way.
Mice: a single group. Cells, worms or flies and humans: nothing yet.
- 1 lab in 1 country
- Funder: National Institute of Environmental Health Sciences
- Humans1
- Animals1
- Model organisms1
Effects
2Cellular senescence
downin mice1
1 study
Cellular senescence
downin mice1
REV1 prevents cellular senescence in Rev1/Xpc double mutant mice.
“This was associated with replication stress, genomic breaks, DNA damage signaling, senescence, and apoptosis in bone marrow.”
Animalsin Rev1/Xpc double mutant micebone marrow
Blood
Aplastic anemia
downin mice1
1 study
Aplastic anemia
downin mice1
REV1 prevents aplastic anemia in mice (deficient for Rev1 and Xpc).
“The additional disruption of Xpc, essential for global-genome nucleotide excision repair (ggNER) of helix-distorting nucleotide lesions, resulted in the perinatal loss of hematopoietic stem cells, progressive loss of bone marrow, and fatal aplastic anemia between 3 and 4 months of age.”
Animalsdeficient for Rev1 and Xpc
Blood
Latest
JID Innovations
Translesion Synthesis DNA Polymerase Gene Expression Is Impacted by Age and IGF-1 in Epidermal Human Skin
Study in peopleSkin